SPOTLIGHT: A little pain relief for Merck

After months of bad news about the company's Cox-2 painkiller Vioxx, things are upbeat at Merck today after word of a successful final stage trial of its cervical cancer vaccine Gardasil. Researchers say the vaccine works by stopping HP 16 and HP 18, two common viruses which have been shown to cause the majority of cervical cancers. Article

Post a comment